IntelGenx Technologies Corp.: debt financing — IntelGenx enters amended loan with ATAI; gets $1M now, $1M milestone loan; issues 4M warrants

IntelGenx Technologies Corp.

New $1M First Tranche loan disbursed within 3 business days of March 11; $1M Second Tranche tied to successful VLS-01 OTF Ph1 readout.
Conversion price for First Tranche set at US$0.185/share; Second Tranche uses greater of $0.185 or 5-day VWAP less max TSX discount.
4,000,000 warrants issued to ATAI at US$0.17/share, exercisable for 36 months; all securities unregistered under Section 4(a)(2).
Existing loans amended and restated; Additional Term Loans mature Feb 1, 2026; interest at 14% per annum on new loans.
Proceeds used for general corporate purposes, working capital, R&D.

item 1.01 item 2.03 item 3.02

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

IntelGenx Technologies Corp. incurred term loan of US$1,000,000 with ATAI Life Sciences AG maturing February 1, 2026.

Instrument: term loan
Principal: US$1,000,000
Counterparty: ATAI Life Sciences AG
Maturity: February 1, 2026
Event: incurrence

Exact text from the filing

(i) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed within three (3) business days of the execution of the Loan Agreement (the " First Tranche Loan ")

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

IntelGenx Technologies Corp. incurred term loan of US$1,000,000 with ATAI Life Sciences AG maturing February 1, 2026.

Instrument: term loan
Principal: US$1,000,000
Counterparty: ATAI Life Sciences AG
Maturity: February 1, 2026
Event: incurrence

Exact text from the filing

(ii) one (1) additional term loan in the amount of US$1,000,000 to IntelGenx Corp., which loan is to be disbursed upon the achievement of a pre-defined milestone (the " Second Tranche Loan "

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IntelGenx Technologies Corp. amended Third Amended and Restated Loan Agreement with ATAI Life Sciences AG (effective 2024-03-11).

Action: amendment
Agreement: credit facility
Counterparty: ATAI Life Sciences AG
Effective: 2024-03-11

Exact text from the filing

IntelGenx Technologies Corp. (the " Corporation ") entered into a Third Amended and Restated Loan Agreement dated March 11, 2024 (the " Loan Agreement ") with its wholly-owned subsidiary, IntelGenx Corp., and ATAI Life Sciences AG (" atai "), which amends and restates the Second Amended and Restated Loan Agreement

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0001062993-24-007044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.